Product Images Enpresse

Not available.*

This text is a list of several studies that investigated the use of contraceptives among women from various countries. The studies are divided into "Ever use" and "Current use," and demonstrate the effect estimates (OR/RR) for each one. However, there is also some garbled and unreadable text that cannot be interpreted.*

This is a description for Enpresse, a medication consisting of levonorgestrel and ethinyl estradiol tablets USP in a triphasic regimen. The medication is packaged into 6 cyclic tablet dispensers, each with 28 tablets to be taken daily for 28 consecutive days per menstrual cycle. The tablets are color-coded and need to be taken in the following order: 6 pink tablets, 5 white tablets, 10 orange tablets, and 7 light-green tablets. The medication should be stored at room temperature and protected from light and humidity after removing the aluminum-foil overwrap. Each foil pouch contains important patient labeling and brief summary insert for the prescription. The medication is manufactured by Teva Pharmaceuticals USA, Inc. in North Wales, PA.*

This is a description of Enpresse, an oral contraceptive. It contains six cyclc tablet dispensers with a total of 28 tablets. The tablets come in different colors--six pink tablets contain 0.050 mg levonorgestrel and 0.030 mg ethinyl estradiol; five white tablets contain 0.075 mg levonorgesirel and 0.040 mo ethinyl estradik; ten orange tablets contain 0.125 mg levonorgestrel and 0.030 mg ethinyl eswadicl; and seven light-green tablets. This product is intended to prevent pregnancy, but it does not protect against sexually transmitted diseases, including HIV. The text contains various other details such as a product code, manufacturer details, and markings for the packaging.*